Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of Crestor (rosuvastatin) and (Lipitor)
atorvastatin on urinary protein excretion over 1 year in patients with Type 1 or 2 diabetes
with moderate proteinuria and hypercholesterolaemia.